Home LiteratureArticle Details
PMID: 7937814 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.

Plump AS, Scott CJ, Breslow JL

Abstract

Atherosclerosis is a complex disease with both genetic and environmental determinants. Apolipoprotein (Apo) E-deficient mice have been created that are highly susceptible to atherosclerosis. In order to assess the role of human apolipoprotein (hApo) A-I and high density lipoprotein (HDL) in atherosclerosis susceptibility, transgenic mice overexpressing the hApo A-I gene were crossed with Apo E-deficient mice. Apo E-/-, hApo A-I mice with two-fold elevation in HDL cholesterol have markedly diminished atherosclerosis with less fibroproliferative lesions by 8 months of age. A strong reciprocal relationship between HDL cholesterol levels and atherosclerosis was found with HDL levels accounting for 78% of the observed variance in mean lesion area. The effect of HDL on atherosclerosis resistance was independent of non-HDL cholesterol.

MeSH Terms
Aging/physiology Animals Aorta/cytology,growth & development,pathology Apolipoprotein A-I/biosynthesis Apolipoproteins E/deficiency Arteriosclerosis/prevention & control Cholesterol/blood Cholesterol, HDL/blood Crosses, Genetic Gene Expression Humans Lipoproteins, LDL/biosynthesis,blood Mice Mice, Inbred C57BL Mice, Inbred CBA Mice, Transgenic Muscle Development Muscle, Smooth, Vascular/cytology,growth & development,pathology
Chemicals
Apolipoprotein A-I Apolipoproteins E Cholesterol, HDL Lipoproteins, LDL Cholesterol
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Plump A S
Rockefeller University, New York, NY 10021.
Scott C J
Breslow J L
References (20)
20 references, click to expand
  1. Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease.
    Arteriosclerosis. 1982 Jan-Feb;2(1):16-26 PMID: 6800349
  2. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.
    Arterioscler Thromb. 1994 Jan;14(1):141-7 PMID: 8274470
  3. High density lipoprotein metabolism.
    J Lipid Res. 1984 Oct;25(10):1017-58 PMID: 6392459
  4. Variation in susceptibility to atherosclerosis among inbred strains of mice.
    Atherosclerosis. 1985 Oct;57(1):65-73 PMID: 3841001
  5. Quantitative assessment of atherosclerotic lesions in mice.
    Atherosclerosis. 1987 Dec;68(3):231-40 PMID: 3426656
  6. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
    Circulation. 1989 Jan;79(1):8-15 PMID: 2642759
  7. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
    J Biol Chem. 1989 Apr 15;264(11):6488-94 PMID: 2495286
  8. High-density lipoprotein--the clinical implications of recent studies.
    N Engl J Med. 1989 Nov 9;321(19):1311-6 PMID: 2677733
  9. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.
    J Clin Invest. 1990 Apr;85(4):1234-41 PMID: 2318976
  10. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.
    J Clin Invest. 1991 Jan;87(1):371-6 PMID: 1898657
  11. Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene.
    Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2793-7 PMID: 1901417
  12. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Nature. 1991 Sep 19;353(6341):265-7 PMID: 1910153
  13. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.
    Proc Natl Acad Sci U S A. 1992 May 15;89(10):4471-5 PMID: 1584779
  14. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.
    Science. 1992 Oct 16;258(5081):468-71 PMID: 1411543
  15. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.
    Cell. 1992 Oct 16;71(2):343-53 PMID: 1423598
  16. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.
    Science. 1993 Jul 23;261(5120):469-72 PMID: 8332912
  17. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
    Nature. 1993 Oct 21;365(6448):762-4 PMID: 8413656
  18. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans.
    J Lipid Res. 1993 Oct;34(10):1637-59 PMID: 8245716
  19. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
    Arterioscler Thromb. 1994 Jan;14(1):133-40 PMID: 8274468
  20. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease.
    N Engl J Med. 1982 Jun 24;306(25):1513-9 PMID: 7078608
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1994-09-27
Pages
9607-11
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC44862
Subset
IM
Grants
NHLBI NIH HHS · HL32435-10 · United States
NHLBI NIH HHS · HL33714-10 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com